MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$52,955K
Net loss
-$52,701K
(13.64%↑ Y/Y)
Adjustment to carrying
value of series a...
$254K
Partnership revenue
$32,871K
(1539.45%↑ Y/Y)
Product
$611K
(-3.48%↓ Y/Y)
Loss from operations
-$51,807K
(19.43%↑ Y/Y)
Total other (expense)
income
-$894K
(-127.28%↓ Y/Y)
Total revenue
$33,482K
(1169.22%↑ Y/Y)
Change in the fair value
of derivative...
$254K
Total expenses
$85,289K
(27.41%↑ Y/Y)
Interest (expense)
income, net
-$1,148K
(-134.21%↓ Y/Y)
Research and development
$58,185K
(35.93%↑ Y/Y)
Selling, general and
administrative
$26,914K
(12.47%↑ Y/Y)
Cost of product
revenues
$190K
(-6.86%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)